A new approach for improving diagnostic accuracy in Alzheimer’s disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset

Alzheimer's disease (AD) and frontal lobe dementia (FLD) show characteristic patterns of regional cerebral blood flow (rCBF). However, these patterns may overlap with those observed in the aging brain in elderly normal individuals. The aim of this study was to develop a new method for better classification and recognition of AD and FLD cases as compared with normal controls. Forty-six patients with AD, 7 patients with FLD and 34 normal controls (CTR) were included in the study. rCBF was assessed by technetium-99m hexamethylpropylene amine oxime and a three-headed single-photon emission tomography (SPET) camera. A brain atlas was used to define volumes of interest (VOIs) corresponding to the brain lobes. In addition to conventional image processing methods, based on count density/voxel, the new approach also analysed other intrinsic properties of the data by means of gradient computation steps. Hereby, five factors were assessed and tested separately: the mean count density/voxel and its histogram, the mean gradient and its histogram, and the gradient angle co-occurrence matrix. A feature vector concatenating single features was also created and tested. Preliminary feature discrimination was performed using a two-sided t-test and a K-means clustering was then used to classify the image sets into categories. Finally, five-dimensional co-occurrence matrices combining the different intrinsic properties were computed for each VOI, and their ability to recognise the group to which each individual scan belonged was investigated. For correct classification of the AD-CTR groups, the gradient histogram in the parieto-temporal lobes was the most useful single feature (accuracy 91%). FLD and CTR were better classified by the count density/voxel histogram (frontal and occipital lobes) and by the mean gradient (frontal, temporal and parietal lobes, accuracy 98%). For AD and FLD the count density/voxel histogram in the frontal, parietal and occipital lobes classified the groups with the highest accuracy (85%). The concatenated joint feature correctly classified 96% of the AD-CTR, 98% of the FLD-CTR and 94% of the AD-FLD cases. 5D co-occurrence matrices correctly recognised 98% of the AD-CTR cases, 100% of the FLD-CTR cases and 98% of the AD-FLD cases. The proposed approach classified and diagnosed AD and FLD patients with higher accuracy than conventional analytical methods used for rCBF-SPET. This was achieved by extracting from the SPET data the intrinsic information content in each of the selected VOIs.

[1]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[2]  Lee-Tzuu Chang,et al.  A Method for Attenuation Correction in Radionuclide Computed Tomography , 1978, IEEE Transactions on Nuclear Science.

[3]  G. Knoll,et al.  Single-photon emission computed tomography , 1983, Proceedings of the IEEE.

[4]  P. Sharp,et al.  The use of 99Tcm-HM-PAO for the diagnosis of dementia. , 1987, Nuclear medicine communications.

[5]  W. Jagust,et al.  Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. , 1989, American journal of physiologic imaging.

[6]  G. Goodwin,et al.  The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis , 1989, Psychological Medicine.

[7]  A. Burns,et al.  Single photon emission tomography in dementia , 1991 .

[8]  T. Greitz,et al.  A computerized brain atlas: construction, anatomical content, and some applications. , 1991, Journal of computer assisted tomography.

[9]  S. Eagger,et al.  Patterns of regional cerebral blood flow in Alzheimer's disease. , 1992, Nuclear medicine communications.

[10]  B L Holman,et al.  The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  T. Greitz,et al.  Transformations and algorithms in a computerized brain atlas , 1992, IEEE Conference on Nuclear Science Symposium and Medical Imaging.

[12]  D. Hamilton,et al.  The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  N. Lassen,et al.  Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[14]  R. Robinson,et al.  Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[15]  A. Brun,et al.  Swedish consensus on dementia diseases. , 1994, Acta neurologica Scandinavica. Supplementum.

[16]  L Thurfjell,et al.  CBA--an atlas-based software tool used to facilitate the interpretation of neuroimaging data. , 1995, Computer methods and programs in biomedicine.

[17]  P Julin,et al.  Clinical diagnosis of frontal lobe dementia and Alzheimer's disease: relation to cerebral perfusion, brain atrophy and electroencephalography. , 1995, Dementia.

[18]  I. Mena,et al.  SPECT in Dementia: Clinical and Pathological Correlation , 1995, Journal of the American Geriatrics Society.

[19]  R. Koeppe,et al.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  E. Ryding SPECT measurements of brain function in dementia; a review , 1996, Acta neurologica Scandinavica. Supplementum.

[21]  S Minoshima,et al.  Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  M F Weiner,et al.  Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. , 1997, Radiology.

[23]  J. Cummings,et al.  Sensitivity, Specificity, and Positive Predictive Value of Technetium 99-HMPAO SPECT in Discriminating Alzheimer's Disease from other Dementias , 1997, Journal of geriatric psychiatry and neurology.

[24]  J. Risberg,et al.  Regional cerebral blood flow measurements in the clinical evaluation of demented patients. , 1997, Dementia and geriatric cognitive disorders.

[25]  L. Thurfjell,et al.  Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans. , 1997, Journal of computer assisted tomography.

[26]  N O'Hare,et al.  Classification of mild Alzheimer's disease by artificial neural network analysis of SPET data , 1997, Nuclear medicine communications.

[27]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  W. Jagust,et al.  Clinical Studies of Cerebral Blood Flow in Alzheimer's Disease , 1997, Annals of the New York Academy of Sciences.

[29]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[30]  K. Jobst,et al.  Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias , 1997, International Psychogeriatrics.

[31]  S. Kinomura,et al.  Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  V. Kovalev,et al.  Classification of SPECT scans of AD and FLD based on intensity and gradient information , 1999 .

[33]  J T O'Brien,et al.  Combined Magnetic Resonance Imaging and Single-Photon Emission Tomography Scanning in the Discrimination of Alzheimer's Disease From Age-Matched Controls , 2001, International Psychogeriatrics.

[34]  D. Salmaso,et al.  Regional cerebral blood flow as assessed by principal component analysis and 99 mTc-HMPAO SPET in healthy subjects at rest : normal distribution and effect of age and gender , 2001 .

[35]  R. V. Van Heertum,et al.  SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.

[36]  F. Kruggel,et al.  Three-dimensional texture analysis of MRI brain datasets , 2001, IEEE Transactions on Medical Imaging.

[37]  Michel Koole,et al.  99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults , 2001, European Journal of Nuclear Medicine.

[38]  Lars Nyberg,et al.  Memory functions and rCBF 99mTc-HMPAO SPET: developing diagnostics in Alzheimer's disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  Bruno Alfano,et al.  Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  H J Testa,et al.  Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia , 2002, Acta neurologica Scandinavica.

[41]  Sanjiv S Gambhir,et al.  Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  G. Walstra,et al.  Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography , 1995, Journal of Neurology.